bioRxiv Science⌕ Search

Biology subjects

Alcami, A.

Publications and source records attributed to Alcami, A..

12 recordsLinked to original sources

Non-cyclic dinucleotide STING agonists abrogate MPXV infection

Mpox has emerged as a global threat to public health following several national and international outbreaks from 2022. Poxviruses deploy multiple strategies to counteract host immune defences including pathways leading to interferon (IFN) production. Here we demonstrate that depleting the viral 23-cGAMP nuclease poxin restores activation of STING and IRF3 during MPXV infection despite the presence of other viral antagonists. We then demonstrate that non-cyclic dinucleotide (non-CDN) STING agonists are resistant to poxin; activate STING and IRF3 during infection; and potently suppress MPXV and orthopoxvirus replication in human primary fibroblasts and differentiated monocytes, where replication is completely abrogated. Mechanistically, non-CDN restriction requires STING, IFNAR and STAT signalling, and induces a unique transcriptional signature over IFN{beta}, enabling expression of additional cytokines. In vivo, non-CDN activity effectively reduces signs of illness and enhances survival in wild-derived castaneous mice inoculated with the virulent clade I MPXV. Our study reveals poxin as an Achilles heel of MPXV, that when bypassed by direct STING agonism, provides a promising novel anti-mpox therapeutic strategy with reduced risk of antiviral resistance.

microbiology↗

Dispersal, adaptation and persistence of H5N1 in the sub-Antarctic and Antarctica

High pathogenicity avian influenza virus (HPAIV) H5N1 reached the sub-Antarctic and Antarctica in 2023, subsequently spreading to remote locations within this region where it had devastating impacts on seal, penguin and albatross populations. The threat to marine wildlife over this broad area exemplifies the need to understand H5N1 long-distance dispersal and evolution. We obtained 104 novel viral genomic sequences from samples that we collected at South Georgia, Kerguelen, Crozet, Prince Edward, Falklands/Malvinas Islands and the Antarctic Peninsula in a region spanning 8,000 kilometers. Using recent phylogeographic modeling advances we show that H5N1 spread encompassed numerous transmission events between distant locations, accumulating mammalian-adaptive mutations in the process. Seals are the most affected species, but we reveal that the long-distance eastward virus dispersal better aligns with the long-distance movements of large petrels and albatrosses. The risk of H5N1 endemisation, dispersal to other locations and ongoing evolution are highly concerning.

microbiology↗

Antarctic Soil Auxiliarome: unraveling the pan-auxiliary metabolic genes catalogue in a transect across different ice-free regions of Antarctica

The Transantarctic Mountains host a significant portion of Antarcticas ice-free soils and support diverse microbial communities, but the role of viruses in these extreme ecosystems remains poorly understood. To address this gap, we conducted the first comprehensive analysis of both RNA and DNA soil viruses across ten locations along a regional-scale latitudinal transect. This study revealed high viral diversity, including the first description of 18 previously unreported viral families in Antarctic soils, alongside significant local viral endemicity. Elevation emerged as the primary driver of viral diversity, while distance to the coast explained the distribution of auxiliary metabolic genes (AMGs), and distance to the sea influenced the metabolic pathways associated with these AMGs. The concept of the "auxiliarome," a pan-AMG catalogue at the community level, underscores the critical role of AMGs in engineering host metabolism. These genes contribute to the metabolism of cofactors and vitamins, amino acids, carbohydrates, and sulfur, as well as ecologically significant traits such as bacterial restriction-modification systems or antibiotic production and resistance. This study expands our understanding of Antarctic soil viruses and highlights their ecological importance in shaping microbial communities and biogeochemical processes in extreme environments.

microbiology↗

Enhanced mouse virulence of mpox virus clade Ib over clade IIb despite genomic changes caused by human-to-human transmission

The recently emerged clade Ib of mpox virus (MPXV) is spreading rapidly across Central and West Africa raising concerns about its potential virulence. Similar to clade IIb lineage B.1, which was responsible for the 2022 global outbreak, clade Ib exhibits sustained human-to-human transmission and a pattern of APOBEC3-associated genomic mutations. Here, we show that clade Ib displays enhanced cell-to-cell dissemination in vitro compared to clade IIb. Additionally, using the CAST mouse model, we show that clade Ib retains a higher level of virulence than that of the markedly attenuated clade IIb. Clade Ib leads to significant weight loss and high mortality in animals following both intraperitoneal and intranasal challenge. Histopathological analysis revealed more severe and extensive lung lesions in clade Ib-infected animals, accompanied by a broader distribution of viral antigens. Moreover, clade Ib, unlike IIb, disseminated efficiently to internal organs. These findings indicate that clade Ib MPXV has not undergone attenuation after human-to-human transmission to the extent observed in clade IIb and underscore the need for surveillance and preparedness against new emerging MPXV lineages.

microbiology↗

Viral soluble decoy receptor as a novel treatment for IFN-I triggered diseases

Besides its antiviral action, type I interferon (IFN-I) plays a key role in triggering the inflammatory response and immunopathology in a group of autoinflammatory disorders known as interferonopathies. Current therapies for these diseases focus on blocking IFN-I signaling at different levels, but with incomplete success. Throughout evolution, to counteract the host immune response, poxviruses have developed decoy receptors, soluble proteins secreted from infected cells during infection that bind and block key host cytokines. One of these, the poxvirus IFN-I binding protein (IFN{beta}BP) is a unique soluble receptor with the ability to block many IFN-I subtypes with broad species specificity. In addition, this protein interacts with glycosaminoglycans on the cell surface while binding IFN-I, which enhances its immunomodulatory potential by allowing the retention of this receptor around the site of infection. In this study, we have deepened into how the poxvirus IFN{beta}BP modulates IFN-I to apply this knowledge to the development of new anti-IFN-I therapeutics. With this purpose, a set of IFN{beta}BP-based recombinant proteins were generated and tested for their ability to neutralize IFN-I and bind to the cell surface in vitro, and their immunomodulatory action was tested in the mousepox model of pathogenesis. Finally, the therapeutic potential of some of these selected viral IFN-I inhibitors was validated in two different murine models of autoinflammatory disease, imiquimod-induced psoriasis and pristane-induced lupus.

immunology↗

New minimally invasive techniques for sample collection in Antarctic seals

Remote or minimally invasive sampling techniques are essential in wildlife research, particularly for Antarctic seals. These methods reduce handling time, minimize animal stress, and improve biosecurity by preventing pathogen transmission, especially relevant during the current outbreak of highly pathogenic avian influenza affecting Antarctic megafauna. Research on ice-dependent seals is logistically challenging and often requires chemical immobilization, which is costly, time-consuming, and poses risks to both animals and researchers. To overcome these limitations, we developed a simple, low-cost remote sampling device to collect nasal swabs from seals without physical contact. The device consists of a telescopic pole with a swab attached to its end. Researchers approached seals resting on ice floes or land using inflatable boats, without disembarking, thus minimizing field exposure. Over ten days, we collected ten nasal swabs from leopard seals (Hydrurga leptonyx, n=4), Weddell seals (Leptonychotes weddellii, n=4), and southern elephant seals (Mirounga leonina, n=2). All samples tested negative for avian influenza virus (INF-A) using RT-qPCR. This methodology is adaptable to various species and conditions, requires minimal equipment, and can be implemented by small teams. It provides a safe, efficient tool for disease surveillance in remote polar environments, advancing marine mammal research while minimizing disturbance to wildlife.

zoology↗

The expanding avian influenza panzootic: skua die-off in Antarctica

High pathogenicity avian influenza virus of subtype H5 (H5 HPAIV), clade 2.3.4.4b, invaded Antarctica in 2023. Here we show that H5 HPAIV caused high mortality in a breeding colony of skuas at one of ten sites we visited in March 2024. By combined virological and pathological analyses, we found that H5 HPAIV caused multi-organ necrosis and rapid death in skuas. Taken together with recent data, skuas in Antarctica are at risk of continued mortality from H5 HPAIV infection, threatening their already small populations. Conversely, because of their wide distribution and ecological relevance, skuas may play a substantial role in spread of the virus across Antarctica. Transdisciplinary surveillance is needed in coming years to monitor the impact of this poultry-origin disease on Antarcticas unique wildlife.

microbiology↗

Attenuation of the 2022 global outbreak monkeypox virus relative to its clade IIb ancestor

Monkeypox virus (MPXV) is a zoonotic virus endemic to Africa that has recently re-emerged, becoming the first orthopoxvirus with human-to-human transmission since smallpox eradication. The 2022 global epidemic of MPXV was caused by Clade IIb lineage B.1 virus that derives from the Clade IIb lineage A.1, which is endemic to West Africa1-3. Here we compared an early lineage B.1 virus with its closest earlier A.1 ancestor and show that despite only 46 nucleotide differences, lineage B.1 has attenuating phenotypic changes. Both B.1 and A.1 viruses replicated equivalently in cell culture, but B.1 had defects in long-range spread. MPXV B.1 also displayed defects in innate immune control, inducing higher IFN{beta}, innate immune signalling and MAPK gene expression, and a reduced capacity to suppress interleukin-1{beta}-mediated immune responses. Finally, MPXV B.1 had reduced virulence in a mouse model of MPXV infection relative to the ancestral A.1 endemic strain. Our work demonstrates biological differences between human circulating MPXV lineages that correlate with clinical observations documenting reduced in-host viral dissemination and disease severity for lineage B. Our data also reveal that the APOBEC3-like mutational footprint in MPXV is not only a signature of sustained human transmission but can also drive phenotypic changes.

microbiology↗

High-throughput engineering of cytoplasmic- and nuclear-replicating large dsDNA viruses by CRISPR/Cas9

The application of CRISPR/Cas9 to improve genome engineering efficiency of large dsDNA viruses has been extensively described, but a robust and versatile method for high-throughput generation of marker-free recombinants for a desire locus has not been reported yet. Cytoplasmic-replicating viruses use their own repair enzymes for homologous recombination, while nuclear-replicating viruses use the host repair machinery. This is translated into a wide range of Cas9-induced homologous recombination efficiency depending on the virus replication compartment and viral/host repair machinery characteristics and accessibility. However, the use of Cas9 as a selection agent to target parental virus genomes robustly improves the selection of desired recombinants across large dsDNA viruses. We used ectromelia virus (ECTV) and herpes simplex viruses (HSV) type 1 and 2, to optimize a CRISPR/Cas9 method that can be versatilely used for efficient genome editing and selection of both cytoplasmic- and nuclear-replicating viruses. We performed a genome-wide genetic variant analysis of mutations located at predicted off-target sequences for 20 different recombinants, showing off-target-free accuracy by deep-sequencing. Our results support this optimized method as an efficient, accurate and versatile approach to enhance the two critical factors of high-throughput viral genome engineering: generation and color-based selection of recombinants. This application of CRISPR/Cas9 reduces time and labor of screening of desired recombinants, allowing for high-throughput generation of large collections of mutant dsDNA viruses for a desire locus in less than two weeks. DATA SUMMARYRaw sequence reads are available at the European Bioinformatics Institute (EMBL-EBI) European Nucleotide Archive (ENA) as Bioproject ID PRJEB32151 and PRJEB32152. Six supplementary figures, eleven supplementary tables and supplementary methods are available with the online version of this article. The authors confirm all supporting data, code and protocols have been provided within the article or through supplementary data files.

microbiology↗

Herpes simpex virus 2 (HSV-2) evolves faster in cell culture than HSV-1 by generating greater genetic diversity

Herpes simplex virus type 1 and 2 (HSV-1 and HSV-2, respectively) are prevalent human pathogens of clinical relevance that establish long-life latency in the nervous system. They have been considered, along with the Herpesviridae family, to exhibit a low level of genetic diversity during viral replication. However, the high ability shown by these viruses to rapidly evolve under different selective pressures does not correlates with that presumed genetic stability. High-throughput sequencing has revealed that heterogeneous or plaque-purified populations of both serotypes contain a broad range of genetic diversity, in terms of number and frequency of minor genetic variants, both in vivo and in vitro. This is reminiscent of the quasispecies phenomenon traditionally associated with RNA viruses. Here, by plaque-purification of two selected viral clones of each viral subtype, we reduced the high level of genetic variability found in the original viral stocks, to more genetically homogeneous populations. After having deeply characterized the genetic diversity present in the purified viral clones as a high confidence baseline, we examined the generation of de novo genetic diversity under culture conditions. We found that both serotypes gradually increased the number of de novo minor variants, as well as their frequency, in two different cell types after just five and ten passages. Remarkably, HSV-2 populations displayed a much higher raise of nonconservative de novo minor variants than the HSV-1 counterparts. Most of these minor variants exhibited a very low frequency in the population, increasing their frequency over sequential passages. These new appeared minor variants largely impacted the coding diversity of HSV-2, and we found some genes more prone to harbor higher variability. These data show that herpesviruses generate de novo genetic diversity differentially under equal in vitro culture conditions. This might have contributed to the evolutionary divergence of HSV-1 and HSV-2 adapting to different anatomical niche, boosted by selective pressures found at each epithelial and neuronal tissue. AUTHOR SUMMARYHerpesviruses are highly human pathogens that establish latency in neurons of the peripheral nervous system. Colonization of nerve endings is required for herpes simplex virus (HSV) persistence and pathogenesis. HSV-1 global prevalence is much higher than HSV-2, in addition to their preferential tendency to infect the oronasal and genital areas, respectively. How these closely related viruses have been adapting and evolving to replicate and colonize these two different anatomical areas remains unclear. Herpesviruses were presumed to mutate much less than viruses with RNA genomes, due to the higher fidelity of the DNA polymerase and proofreading mechanisms when replicating. However, the worldwide accessibility and development of high-throughput sequencing technologies have revealed the heterogenicity and high diversity present in viral populations clinically isolated. Here we show that HSV-2 mutates much faster than HSV-1, when compared under similar and controlled cell culture conditions. This high mutation rate is translated into an increase in coding diversity, since the great majority of these new mutations lead to nonconservative changes in viral proteins. Understanding how herpesviruses differentially mutate under similar selective pressures is critical to prevent resistance to anti-viral drugs.

microbiology↗

Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate

Antiviral strategies to inhibit Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and the pathogenic consequences of COVID-19 are urgently required. Here we demonstrate that the NRF2 anti-oxidant gene expression pathway is suppressed in biopsies obtained from COVID-19 patients. Further, we uncover that NRF2 agonists 4-octyl-itaconate (4-OI) and the clinically approved dimethyl fumarate (DMF) induce a cellular anti-viral program, which potently inhibits replication of SARS-CoV2 across cell lines. The anti-viral program extended to inhibit the replication of several other pathogenic viruses including Herpes Simplex Virus-1 and-2, Vaccinia virus, and Zika virus through a type I interferon (IFN)-independent mechanism. In addition, induction of NRF2 by 4-OI and DMF limited host inflammatory responses to SARS-CoV2 infection associated with airway COVID-19 pathology. In conclusion, NRF2 agonists 4-OI and DMF induce a distinct IFN-independent antiviral program that is broadly effective in limiting virus replication and suppressing the pro-inflammatory responses of human pathogenic viruses, including SARS-CoV2. One Sentence SummaryNRF2 agonists 4-octyl-itaconate (4-OI) and dimethyl fumarate inhibited SARS-CoV2 replication and virus-induced inflammatory responses, as well as replication of other human pathogenic viruses.

microbiology↗

Poxvirus-encoded TNF receptor homolog dampens inflammation and protects the host from uncontrolled lung pathology and death during respiratory infection

Ectromelia virus (ECTV) causes mousepox, a surrogate mouse model for smallpox caused by variola virus in humans. Both viruses encode tumor necrosis factor receptor (TNFR) homologs termed cytokine response modifier (Crm) proteins, containing a TNF-binding domain and a chemokine-binding domain termed smallpox virus-encoded chemokine receptor (SECRET) domain. Infection of ECTV-resistant C57BL/6 mice with an ECTV CrmD deletion mutant resulted in uniform mortality due to excessive TNF secretion and dysregulated inflammatory cytokine production but viral load was not affected. CrmD dampened lung pathology, leukocyte recruitment and inflammatory cytokines including TNF, IL-6, IL-10 and IFN-{gamma}. Blockade of IL-6, IL-10R or TNF function with monoclonal antibodies reduced lung pathology and provided 60-100% protection from an otherwise lethal infection. IFN-{gamma} caused lung pathology only when both the TNF-binding and SECRET domains were deleted but it was neither necessary nor sufficient to cause pathology when only the CrmD SECRET domain was expressed by virus.

immunology↗